Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375698 | Bioorganic & Medicinal Chemistry Letters | 2009 | 5 Pages |
Optimization of the amino acid residue within a series of anthranilimide-based glycogen phosphorylase inhibitors is described. These studies culminated in the identification of anthranilimides 16 and 22 which displayed potent in vitro inhibition of GPa in addition to reduced inhibition of CYP2C9 and excellent pharmacokinetic properties.
Graphical abstractOptimization of the amino acid residue within a series of anthranilimide-based glycogen phosphorylase inhibitors is described. These studies culminated in the identification of anthranilimides 16 and 22 which displayed potent in vitro inhibition of GPa in addition to reduced inhibition of CYP2C9 and excellent pharmacokinetic properties.Figure optionsDownload full-size imageDownload as PowerPoint slide